Mount Sinai awards $ 25,000 research grant to help assess impacts of COVID-19
NYC Health + Hospitals and Mount Sinai Arnhold Institute for Global Health Announce First Winners of Cure-19 Research Grants and Pilot Projects
CURE-19 research pilot projects will support further research on COVID-19 over the next five years
The winners will each receive $ 25,000 to help their work
New York, New York State
NYC Health + Hospitals and the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) today announced the first four winners of the CURE-19 research pilots, an initiative to support Interdisciplinary COVID-19 collaboration is researching to better understand the new virus that has transformed healthcare globally. Each winner will each receive $ 25,000 to support their research project with funding from Icahn Mount Sinai.
The CURE-19 research pilot projects will support further COVID-19 research over the next five years, with a focus on projects related to disease control for large communities, computing and support systems. decision, addressing structural racism and the social determinants of health, translational science, research, and evidence-based interventions and policies. The projects will also address the long-term effects of COVID-19, the social and environmental determinants of COVID-19, and maternal and child health related to COVID-19.
“Elmhurst is excited to collaborate with our colleagues on Mount Sinai to better understand the relationship between COVID-19 and community, clinical and socio-economic variables,” said NYC Health + Hospitals / Elmhurst CEO Helen Arteaga Landaverde, MPH. “We saw firsthand how terribly our precious community was affected in the early days and weeks of the pandemic. However, this impact will have lasting effects for decades and generations to come. As community health care providers, it is essential to understand these impacts and to better tailor our care and support services to these needs. “
“Congratulations to the first four fellows of the CURE-19 research pilot projects,” said NYC Health + Hospitals / Queens CEO Neil J. Moore, MBA, MPA, FACHE. “By partnering with our neighboring health facilities, our experts will be able to collect larger samples of information to draw more solid conclusions and correlations that will ultimately help meet the health needs of these communities today.” hui and in the future. “
“We are delighted to fund the first cohort of research studies under the CURE-19 collaboration with NYC Health + Hospitals,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and President of Academic Affairs of the Mount Sinai Health System. “The pandemic has disproportionately affected vulnerable populations. We must understand systemic issues in order to address inequalities in medicine and provide equitable care that improves health outcomes and strengthens pandemic preparedness and response initiatives. “
The first research grant winners and their projects include:
- Environmental impact on results: Saadiyah Bilal, MD, MPH, Assistant Professor of Emergency Medicine at Icahn Mount Sinai, will examine the relationship between neighborhood-level community variables with clinical outcomes and vaccination rates for patients with COVID-19 .
- Community health workers: Stanley Pierre, MD, MPA Patient Safety Coordinator and Director of the Clinical Centers of Excellence Development Program, NYC Health + Hospitals / Queens will examine how community health workers can promote equity in access to vaccines and trust in historically marginalized and vulnerable communities.
- Maternal COVID-19 vaccination: Uday Patil, MD, Director of Neonatal and Newborn Services at NYC Health + Hospitals / Elmhurst, and Assistant Professor of Pediatrics and Global Health and Health Systems Design at Icahn Mount Sinai, will review the transfer of passive immunity to COVID-19 in newborns following vaccination of mothers in diverse and multi-ethnic communities that are often underserved and under-represented.
- Opioid overdose during the pandemic: Siri Shastry, MD, MS, assistant professor of emergency medicine at Icahn Mount Sinai, to examine the impact of COVID-19 on risk behaviors of patients with non-fatal opioid overdoses in the ward emergencies, while understanding the influence of structure, community and network factors.
” , said Board Member Carlina Rivera, President of the Hospitals Committee. “Over the next five years, Dr Bilal, Dr Pierre, Dr Patil and Dr Shastry will lead critical research on the impacts of COVID-19 on our city, our country and the world. I applaud their work and dedication to public health, and look forward to their findings that will ultimately serve our most vulnerable communities. “
The first four recipients of the research grant were required to submit a proposal, which included a summary or summary of the project, a description of the research emphasizing its objective and importance, the proposed timeline, the list of principal investigators and co-principals, and more. The proposals were reviewed by a committee of research leaders from CURE-19 partner institutions, who assessed criteria such as overall impact, significance, innovation and approach.
The research pilots are part of a larger partnership known as the COVID-19 Unit for Research at NYC Health + Hospitals / Elmhurst and / Queens (CURE-19), a collaboration between the Arnhold Institute for Global Health from Mount Sinai and NYC Health + Hospitals / Elmhurst Global Health Institute which formed during the initial peak of the pandemic in 2020. CURE-19 translates data, experiences and lessons from clinicians at Mount Sinai Health System, NYC Health + Hospitals / Elmhurst and NYC Health + Hospitals / Queens in research to address both the global pandemic and the root causes of health disparities in New York City.